Colchicine

Generic Name
Colchicine
Brand Names
Colcrys, Gloperba, Lodoco, Mitigare
Drug Type
Small Molecule
Chemical Formula
C22H25NO6
CAS Number
64-86-8
Unique Ingredient Identifier
SML2Y3J35T
Background

Colchicine is an alkaloid drug derived from a plant belonging to the Lily family, known as Colchicum autumnale, or "autumn crocus." Its use was first approved by the FDA in 1961. Colchicine is used in the treatment of gout flares and Familial Mediterranean fever, and prevention of major cardiovascular events. It has also been investigated in other inflammato...

Indication

Colchicine is indicated for the prophylaxis and treatment of gout flares. It is also indicated in Familial Mediterranean fever (FMF) in children and adults of four years of age and older. It is also indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established ather...

Associated Conditions
Behcet's Syndrome, Cardiovascular Mortality, Coronary Revascularization, Familial Mediterranean Fever (FMF ), Gout Flares, Myocardial Infarction, Pericarditis, Postpericardiotomy Syndrome, Stroke
Associated Therapies
-

Drug-Drug Interaction Study of Colchicine and Azithromycin

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2009-10-28
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00983294

Drug-Drug Interaction Between Colchicine and Ritonavir

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2009-10-15
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00983515
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, East Grand Forks, Minnesota, United States

Drug-Drug Interaction Between Colchicine and Verapamil ER

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2009-10-15
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00983242
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, East Grand Forks, Minnesota, United States

Drug-Drug Interaction Study of Colchicine and Clarithromycin

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2009-10-15
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00984061
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

A Drug-Food Interaction Study Between Colchicine and Grapefruit Juice

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-09-24
Last Posted Date
2011-11-21
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00984009
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis

Not Applicable
Conditions
Interventions
First Posted Date
2009-09-23
Last Posted Date
2010-07-20
Lead Sponsor
Bnai Zion Medical Center
Target Recruit Count
80
Registration Number
NCT00983177
Locations
🇮🇱

Bnai Zion Medical Center, Haifa, Israel

Drug-Food Interaction Study of Seville Orange Juice and Colchicine

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-17
Last Posted Date
2011-06-08
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00960193
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Drug-Drug Interaction Study Between Colchicine and Atorvastatin

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-08-17
Last Posted Date
2010-03-30
Lead Sponsor
Mutual Pharmaceutical Company, Inc.
Target Recruit Count
24
Registration Number
NCT00960323
Locations
🇺🇸

PRACS Institute, Ltd. - Cetero Research, Fargo, North Dakota, United States

Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2009-02-10
Last Posted Date
2013-01-31
Lead Sponsor
Hospital Universitario Ramon y Cajal
Target Recruit Count
50
Registration Number
NCT00840489
Locations
🇪🇸

Hospital Universitario Ramon y Cajal, Madrid, Spain

🇪🇸

Hospital General Universitario Gregorio Marañón, Madrid, Spain

🇪🇸

Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain

A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)

First Posted Date
2009-01-09
Last Posted Date
2018-07-17
Lead Sponsor
Novartis Pharmaceuticals
Target Recruit Count
432
Registration Number
NCT00819585
Locations
🇺🇸

Talbert Medical Group, Huntington Beach, California, United States

🇺🇸

Health Awareness, Jupiter, Florida, United States

🇺🇸

East-West Medical Research institute, Honolulu, Hawaii, United States

and more 28 locations
© Copyright 2024. All Rights Reserved by MedPath